Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 1 of 4: Relative cell counts and normalized growth rate inhibition values across technical replicates. - Dataset - HMS LINCS Database

Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 1 of 4: Relative cell counts and normalized growth rate inhibition values across technical replicates. - Dataset (ID:20268)

Download: Excel (XLSX), Comma-separated (CSV)

<<<<

Select the entities to show:

Small molecules	Cells	Antibodies

|<
<<
Previous
Page 3117 of 3330
Next
>>
>
77901 to 77925 of 83232 records
per page:

Cell	Clinical Subtype	Transcriptional Subtype	Small Molecule	Perturbagen Target	Perturbagen Class	Perturbagen Concentration	Perturbagen Conc Unit	Biological Replicate ID	Relative Cell Count	Normalized Growth Rate Inhibition Value	Nominal Division Rate
BT-549	TNBC	Basal B	Triciribine	AKT	AKT	0.267	uM	5910.074	0.8989	0.9348	3.2172
BT-549	TNBC	Basal B	Triciribine	AKT	AKT	1.33	uM	5910.074	0.8406	0.8949	3.2172
BT-549	TNBC	Basal B	Triciribine	AKT	AKT	6.67	uM	5910.074	0.6400	0.7410	3.2172
BT-549	TNBC	Basal B	Triciribine	AKT	AKT	33.3	uM	5910.074	0.5471	0.6581	3.2172
CAMA-1	HR+	Luminal	Triciribine	AKT	AKT	0.0000853	uM	5911.074	0.8882	0.8010	1.1317
CAMA-1	HR+	Luminal	Triciribine	AKT	AKT	0.000427	uM	5911.074	0.8750	0.7775	1.1317
CAMA-1	HR+	Luminal	Triciribine	AKT	AKT	0.00213	uM	5911.074	0.9217	0.8609	1.1317
CAMA-1	HR+	Luminal	Triciribine	AKT	AKT	0.0107	uM	5911.074	0.8771	0.7811	1.1317
CAMA-1	HR+	Luminal	Triciribine	AKT	AKT	0.0533	uM	5911.074	0.8669	0.7628	1.1317
CAMA-1	HR+	Luminal	Triciribine	AKT	AKT	0.267	uM	5911.074	0.7965	0.6358	1.1317
CAMA-1	HR+	Luminal	Triciribine	AKT	AKT	1.33	uM	5911.074	0.7099	0.4775	1.1317
CAMA-1	HR+	Luminal	Triciribine	AKT	AKT	6.67	uM	5911.074	0.5854	0.2460	1.1317
CAMA-1	HR+	Luminal	Triciribine	AKT	AKT	33.3	uM	5911.074	0.4907	0.0662	1.1317
CAMA-1	HR+	Luminal	Triciribine	AKT	AKT	0.0000853	uM	5912.074	0.9525	0.8975	0.9249
CAMA-1	HR+	Luminal	Triciribine	AKT	AKT	0.000427	uM	5912.074	0.9913	0.9811	0.9249
CAMA-1	HR+	Luminal	Triciribine	AKT	AKT	0.00213	uM	5912.074	0.9493	0.8906	0.9249
CAMA-1	HR+	Luminal	Triciribine	AKT	AKT	0.0107	uM	5912.074	0.9882	0.9745	0.9249
CAMA-1	HR+	Luminal	Triciribine	AKT	AKT	0.0533	uM	5912.074	0.9247	0.8378	0.9249
CAMA-1	HR+	Luminal	Triciribine	AKT	AKT	0.267	uM	5912.074	0.8654	0.7106	0.9249
CAMA-1	HR+	Luminal	Triciribine	AKT	AKT	1.33	uM	5912.074	0.8262	0.6271	0.9249
CAMA-1	HR+	Luminal	Triciribine	AKT	AKT	6.67	uM	5912.074	0.6338	0.2216	0.9249
CAMA-1	HR+	Luminal	Triciribine	AKT	AKT	33.3	uM	5912.074	0.5922	0.1350	0.9249
HBL-100	Unknown	Unknown	Triciribine	AKT	AKT	0.0000853	uM	7429.074	0.9516	0.9580	2.3375
HBL-100	Unknown	Unknown	Triciribine	AKT	AKT	0.000427	uM	7429.074	1.0257	1.0219	2.3375
HBL-100	Unknown	Unknown	Triciribine	AKT	AKT	0.00213	uM	7429.074	1.0009	1.0008	2.3375

|<
<<
Previous
Page 3117 of 3330
Next
>>
>
77901 to 77925 of 83232 records
per page:

HMS LINCS Project

Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 1 of 4: Relative cell counts and normalized growth rate inhibition values across technical replicates. - Dataset (ID:20268)